Allscripts Healthcare Solutions Inc. (MDRX): Price and Financial Metrics

Allscripts Healthcare Solutions Inc. (MDRX): $12.62

0.05 (+0.40%)

POWR Rating

Component Grades








Add MDRX to Watchlist
Sign Up

Industry: Medical - Services




#43 of 75

in industry

MDRX Price/Volume Stats

Current price $12.62 52-week high $19.77
Prev. close $12.57 52-week low $11.30
Day low $12.43 Volume 682,100
Day high $12.65 Avg. volume 1,026,479
50-day MA $13.18 Dividend yield N/A
200-day MA $14.22 Market Cap 1.38B

MDRX Stock Price Chart Interactive Chart >


  • MDRX scores best on the Value dimension, with a Value rank ahead of 84.9% of US stocks.
  • The strongest trend for MDRX is in Stability, which has been heading up over the past 132 days.
  • MDRX ranks lowest in Stability; there it ranks in the 20th percentile.

MDRX Stock Summary

  • With a year-over-year growth in debt of -52.38%, VERADIGM INC's debt growth rate surpasses merely 5.44% of about US stocks.
  • As for revenue growth, note that MDRX's revenue has grown -39.73% over the past 12 months; that beats the revenue growth of merely 6.89% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MDRX comes in at 34.19% -- higher than that of 94.59% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to VERADIGM INC, a group of peers worth examining would be SCWX, VMEO, AXTI, ALKS, and ATEN.
  • MDRX's SEC filings can be seen here. And to visit VERADIGM INC's official web site, go to

MDRX Valuation Summary

  • In comparison to the median Healthcare stock, MDRX's price/sales ratio is 57.5% lower, now standing at 1.7.
  • Over the past 243 months, MDRX's price/sales ratio has gone down 0.3.

Below are key valuation metrics over time for MDRX.

Stock Date P/S P/B P/E EV/EBIT
MDRX 2023-09-18 1.7 1.2 23.6 14.8
MDRX 2023-09-15 1.6 1.1 22.0 13.6
MDRX 2023-09-14 1.6 1.2 22.5 13.9
MDRX 2023-09-13 1.6 1.2 22.4 13.9
MDRX 2023-09-12 1.6 1.2 22.8 14.1
MDRX 2023-09-11 1.7 1.2 23.0 14.4

MDRX Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 103.21%.
  • Its 3 year cash and equivalents growth rate is now at -43.13%.
  • Its 5 year price growth rate is now at -48.3%.
MDRX's revenue has moved down $584,639,000 over the prior 15 months.

The table below shows MDRX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 837.191 160.811 60.634
2022-06-30 1,054.541 188.56 62.286
2022-03-31 1,277.357 -10.742 148.238
2021-12-31 1,503.037 -75.428 134.438
2021-09-30 1,389.072 -319.092 774.987
2021-06-30 1,421.83 -322.015 759.349

MDRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MDRX has a Quality Grade of C, ranking ahead of 38.48% of graded US stocks.
  • MDRX's asset turnover comes in at 0.496 -- ranking 62nd of 83 Computers stocks.
  • INVE, CLSK, and DGII are the stocks whose asset turnover ratios are most correlated with MDRX.

The table below shows MDRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.496 0.384 1.040
2021-03-31 0.480 0.384 0.931
2020-12-31 0.481 0.376 0.725
2020-09-30 0.524 0.396 -0.018
2020-06-30 0.534 0.394 -0.025
2020-03-31 0.544 0.397 -0.172

MDRX Price Target

For more insight on analysts targets of MDRX, see our MDRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $17.86 Average Broker Recommendation 1.79 (Moderate Buy)

Allscripts Healthcare Solutions Inc. (MDRX) Company Bio

AllScripts Healthcare Solutions provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The company was founded in 1986 and is based in Chicago, Illinois.

MDRX Latest News Stream

Event/Time News Detail
Loading, please wait...

MDRX Latest Social Stream

Loading social stream, please wait...

View Full MDRX Social Stream

Latest MDRX News From Around the Web

Below are the latest news stories about VERADIGM INC that investors may wish to consider to help them evaluate MDRX as an investment opportunity.

Veradigm Inc. Announces Receipt of Nasdaq Delisting Notice and Intent to Appeal

CHICAGO, September 22, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that, on September 20, 2023 and as anticipated in its September 18 release, it received a notice from Nasdaq indicating that the Company’s shares would be delisted due to noncompliance with Nasdaq Listing Rule 5250(c)(1), because the Company did not file its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the "Q1 Form 10-

Yahoo | September 22, 2023

Veradigm Inc. Provides Audit Update and Updates Financial Guidance for 2023

CHICAGO, September 18, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that the work effort to conclude on its previously disclosed accounting and internal control errors has taken longer than previously expected, and more time is needed to complete its audit procedures. As such, today the Company will not be filing its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), or its Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2023, and June 30, 2

Yahoo | September 18, 2023

Melissa Supports Healthcare Practice Management Providers with Project US@ Data Compliance

Federal guidelines embrace importance of patient addresses for health IT developers powering analytics, patient matching, and overall careRANCHO SANTA MARGARITA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Melissa, a leading provider of global data quality, identity verification, and address management solutions, today announced its support of healthcare practice management providers in meeting compliance with Project US@, a federal data initiative to create a unified, industrywide specification f

Yahoo | August 30, 2023

Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing

CHICAGO, August 18, 2023--Veradigm Inc. (NASDAQ: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the "Q1 Form 10-Q") and Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the "Q2 Form

Yahoo | August 18, 2023

Is It Time To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Veradigm Inc. ( NASDAQ:MDRX ), is not the largest company out there, but it saw a decent share price growth in the...

Yahoo | August 11, 2023

Read More 'MDRX' Stories Here

MDRX Price Returns

1-mo -5.96%
3-mo 6.59%
6-mo -2.70%
1-year -24.30%
3-year 56.58%
5-year -10.69%
YTD -28.46%
2022 -4.39%
2021 27.77%
2020 47.12%
2019 1.82%
2018 -33.75%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!